Is pomalidomide currently an imported drug or a domestic version?

Pomalidomide is a new immunomodulator that is mainly used to treat relapsed or refractory multiple myeloma, especially in patients who have failed treatment with lenalidomide and bortezomib. The drug was first developed by Celgene in the United States and has been approved for use in many countries around the world. The version currently on the market in mainland China is an imported original drug and is sold by imported companies. There is no domestic generic version approved for marketing.

At present, pomalidomide has been included in the national medical insurance directory, and patients can purchase it at some domestic tertiary hospitals or DTP pharmacies with a doctor's prescription. Although the inclusion in medical insurance has alleviated certain financial burdens, the price of medicines before reimbursement is still high. Usually a box costs around tens of thousands of yuan. The specific price will fluctuate due to different specifications and regional policy differences. After medical insurance reimburses, the patient's out-of-pocket portion may be reduced to several thousand yuan or even less. It is recommended that patients consult the local medical insurance department or pharmacy to understand the reimbursement ratio and actual payment amount.

In foreign markets, especially in Asian countries, there are also more affordable generic versions of pomalidomide. Among them, the price of generic drugs produced in Laos is only RMB 300 per box, providing an alternative for patients with limited financial conditions. The generic drug is consistent with the original drug in terms of ingredients and dosage. However, due to different production and regulatory standards, patients should choose carefully under the guidance of a doctor when using it, and pay attention to adverse reactions and efficacy evaluation during the medication.

To sum up, pomalidomide is still an imported version of the original drug in China, and there are no domestic generic drugs on the market. For patients covered by medical insurance, using medical insurance to purchase drugs through regular hospitals can significantly reduce financial pressure; for patients who cannot be reimbursed by medical insurance or want to save treatment costs, overseas generic drugs can be considered, but attention should be paid to choosing formal channels and using them under the advice of doctors to ensure the safety and effectiveness of treatment.

Reference materials:https://www.drugs.com/